↓ Skip to main content

Dove Medical Press

Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses

Overview of attention for article published in Neuropsychiatric Disease and Treatment, November 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
58 Mendeley
Title
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses
Published in
Neuropsychiatric Disease and Treatment, November 2013
DOI 10.2147/ndt.s50635
Pubmed ID
Authors

Antonio Ciudad, Ernie Anand, Lovisa Berggren, Marta Casillas, Alexander Schacht, Elena Perrin

Abstract

A considerable proportion of patients suffering from schizophrenia show suboptimal responses to oral antipsychotics due to inadequate adherence. Hence, they are likely to benefit from switching to a long-acting injectable formulation. These post hoc analyses assessed the clinical effects of switching to olanzapine long-acting injection (OLAI) from either oral olanzapine (OLZ) or other antipsychotics (non-OLZ).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 24%
Student > Bachelor 10 17%
Other 9 16%
Student > Master 7 12%
Student > Doctoral Student 3 5%
Other 4 7%
Unknown 11 19%
Readers by discipline Count As %
Medicine and Dentistry 15 26%
Psychology 10 17%
Pharmacology, Toxicology and Pharmaceutical Science 8 14%
Nursing and Health Professions 3 5%
Biochemistry, Genetics and Molecular Biology 3 5%
Other 4 7%
Unknown 15 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2017.
All research outputs
#7,356,343
of 25,374,917 outputs
Outputs from Neuropsychiatric Disease and Treatment
#948
of 3,132 outputs
Outputs of similar age
#64,074
of 226,646 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#7
of 51 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,646 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.